The neuropoietic cytokine cholinergic differentiation factor/leukemia nhibitory factor (CDF/LIF) acts as a trophic factor, enhancing neuronal survival, and as a differentiation factor, altering neuronal gene expression. There Is also evidence that It plays a role in the response of adult neural tissue to inJury. We have exaied this possibility further in rats by analyzing changes in the levels of mRNAs for CDF/LIF and its two receptor subunits in response to peripheral nerve damage in culture and in vivo. Using a quantitative RNase protection assay, we find that CDF/LIF mRNA increases dramatically (176-fold) A striking feature of the neuropeptides induced in cultured neonatal sympathetic neurons by CDF/LIF, CNTF, oncostatin M, and growth promoting factor is that several of these same neuropeptides are also induced in adult sympathetic neurons when the ganglia are damaged by explantation in short-term culture or by axotomy in vivo. For instance, substance P and vasoactive intestinal polypeptide (VIP) are induced both by nerve damage and by application of these neuropoietic cytokines to pure neuronal cultures (4, 6, 7). In response to peripheral nerve damage, VIP is induced in dorsal root ganglia (DRGs) as well (8, 9) . Moreover, CDF/ LIF elevates VIP in dissociated DRG neurons (10). Part of the in vivo response to injury could be mediated by nonneuronal cells in the ganglia, since these cells have been shown to release CDF/LIF (11, 12) . CDF/LIF involvement in the neuropeptide response to nerve damage is further indicated by results from mice in which the CDF/LIF gene was disrupted by homologous recombination. Ganglia from such mutant mice display a much reduced neuropeptide response to culturing or axotomy (13).
ganglia and in adult dorsal root ganglia and sciatic nerve after organ culture for 24 hr. This mRNA is clearly detectable by in situ hybridization only in the nonneuronal cells of these struc- tures. When the sciatic nerve is trinsected in vivo, CDF/LIF mRNA increases sgnlfcantly in the regions Immediatel proximal and distal to the lesion site. The mRNA for the igand binding subunit of the CDF/LIF receptor complex decreases somewhat upon culture and nerve section. The dramatic rise in CDF/LIF mRNA after nerve injury is further evidence that this cytokine is involved in the response to damage, a function that overlaps with its postulated role in wounding or infection in several nonneural tissues.
Mammalian peripheral nerves can regenerate after injury. They also participate in the response to damage of other tissues, such as the inflammatory reaction in arthritis (1) . Both (2) (3) (4) . Members ofthis family recognized thus far include cholinergic differentiation factor/leukemia inhibitory factor (CDF/LIF), ciliary neurotrophic factor (CNTF), oncostatin M, growth promoting activity, , and IL-il (4) . All of these cytokines can regulate gene expression in peripheral neurons, and four of them have also been shown to exert trophic effects on various types of peripheral and central neurons (for review, see ref.
5).
A striking feature of the neuropeptides induced in cultured neonatal sympathetic neurons by CDF/LIF, CNTF, oncostatin M, and growth promoting factor is that several of these same neuropeptides are also induced in adult sympathetic neurons when the ganglia are damaged by explantation in short-term culture or by axotomy in vivo. For instance, substance P and vasoactive intestinal polypeptide (VIP) are induced both by nerve damage and by application of these neuropoietic cytokines to pure neuronal cultures (4, 6, 7) . In response to peripheral nerve damage, VIP is induced in dorsal root ganglia (DRGs) as well (8, 9) . Moreover, CDF/ LIF elevates VIP in dissociated DRG neurons (10) . Part of the in vivo response to injury could be mediated by nonneuronal cells in the ganglia, since these cells have been shown to release CDF/LIF (11, 12) . CDF/LIF involvement in the neuropeptide response to nerve damage is further indicated by results from mice in which the CDF/LIF gene was disrupted by homologous recombination. Ganglia from such mutant mice display a much reduced neuropeptide response to culturing or axotomy (13) .
To further investigate the role of CDF/LIF in the events surrounding nerve damage, we have determined whether the levels of CDF/LIF and its receptor subunits change after nerve and ganglion injury. The major sources of CDF/LIF mRNA under these conditions were also localized by in situ hybridization. Some of these findings have been reported (14) (15) (16) .
MATERIALS AND METHODS
Surgical Procedures and Organ Culture. Adult male and female rats were anesthetized by intraperitoneal injection of sodium pentobarbitol (Nembutol, Abbott; 40 mg/kg). The sciatic nerve was exposed and transected. To ensure that regeneration did not occur, a 3-mm piece of the nerve was removed and the remaining ends were deflected. Care was taken so that surrounding muscles were not damaged. The wound was closed with clips. Each time point is composed of data from nerves of nine animals. At the appropriate time, animals were killed by CO2 inhalation and various regions of the sciatic nerve were dissected and frozen at -700C. Corresponding regions of nerve were removed from the contralateral side of each rat as control.
Fifteen superior cervical ganglia (SCGs) from postnatal day 1 In Situ Hybridization Antisense and sense digoxigeninlabeled CDF/LIF probes were generated using the Ambion (Austin, TX) MEGAscript in vitro transcription kit. In situ hybridization was performed as described (20) . Briefly, 20-pm sections of fixed cultured ganglia and nerve were hybridized overnight at 500C with sense or antisense probes, either probe at 1-2 ug/ml. After RNase digestion, sections were incubated with an anti-digoxigenin antibody (Boehringer Mannheim) and the alkaline phosphatase reaction product was visualized with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
RESULTS

Changes in the mRNAs for CDF/LIF and Its Receptor
Subunits After Organ Culture of the SCGs. To determine whether CDF/LIF mRNA changes in sympathetic ganglia in response to injury, neonatal (P1) and adult SCGs were placed in organ culture. After 24 hr, CDF/LIF mRNA was analyzed using a quantitative RNase protection assay. To standardize the CDF/LIF mRNA values, they were expressed as a ratio to GAPDH, an internal control for total RNA. This ratio also controls for variability in RNA recovery from the tissues, and since the GAPDH sample is quantified in the same sample and gel lane, it controls for variability in processing of the samples. Moreover, GAPDH levels were found not to be altered by nerve damage (see below).
There was a 10-fold induction in the expression of CDF/ LIF mRNA relative to GAPDH mRNA when P1 ganglia were cultured for 24 hr (Fig. 1A) . CDF/LIF mRNA levels increased even more dramatically, however, when adult SCGs were placed in organ culture for 24 hr; the increase was 176-fold over levels in uncultured ganglia (Fig. 1A) . The enormous increase in CDF/LIF mRNA after organ culture of adult ganglia was not paralleled by similar changes in its receptor mRNA expression. The levels of the ligand binding receptor subunit, LIFR, decreased by halfin both cultured P1 and adult ganglia when compared to control values (Fig. 1B) . Expression of the transducing subunit, gp130, remained essentially the same in both P1 and adult SCGs after organ culture for 24 hr (Fig. 1B) .
Expression of CDF/LIF mRNA In Sensory Ganglia and Peripheral Nerve After Organ Culture. As outlined above, motor and sensory neurons are also known to up-regulate certain neuropeptides after injury. To determine whether CDF/LIF mRNA levels change in response to sensory ganglion injury, adult DRGs were cultured for 24 hr and expression of CDF/LIF mRNA was monitored. As is the case for adult sympathetic ganglia, relatively low levels of CDF/LIF mRNA were present in normal adult sensory ganglia. After culture for 24 hr, however, the levels increased 43-fold ( Fig. 2A) , indicating that the CDF/LIF induction is not unique to the SCG. LIFR mRNA also showed a response similar to that of the SCG (Fig. 2B) , decreasing slightly after culture, whereas gp130 mRNA levels remained constant. It is important to note that GAPDH levels measured before and after nerve transection revealed that the mRNA for GAPDH did not change significantly after transection (data not shown).
The large difference in the inducibility of CDF/LIF between P1 and adult sympathetic ganglia (Fig. 1) could be due to the increase in the number of glial cells that occurs during postnatal development. To examine the CDF/LIF response in a tissue composed primarily of glial cells, we examined the effects of organ culture on adult sciatic nerve. In response to 24 hr of organ culture, the expression of CDF/LIF mRNA increased 76-fold over normal adult nerve (Fig. 3A) . LIFR mRNA decreased 4-fold after organ culture, whereas gp130 levels remained constant (Fig. 3B) Twenty-four hours after transection, the mRNA for CDF/LIF was '11-fold higher in the region distal to the transection site and 13-fold higher in the proximal-i region, when compared to their respective undisturbed contralateral regions (Fig. 4) . At 5 days after transection, the expression of CDF/LIF in the distal and proximal-i regions remained higher than the contralateral values. By 14 days after injury, the level of CDF/ LIF in the proximal-i region decreased while levels in the distal region remained essentially the same as those seen at 7 days. CDF/LIF mRNA levels in the proximal-2 region remained relatively unchanged throughout the 2-week period.
The Lignd Binding Receptor Subunit for CDF/LIF Decreases In Response to Sciatic Nerve Transection. Consistent with the results seen when ganglia and nerve were cultured for 24 hr (Figs. 1-3) , LIFR levels in the region immediately proximal and distal to the lesion site begin to decrease 24 hr after transection (Fig. 5) that we find CDF/LIF expressed in nonneuronal cells of ganglia and nerve is consistent with the fact that P1 ganglia contain many fewer glial cells than adult ganglia.
CDF/LIF increases the survival of embryonic sensory neurons in vitro (23) and was recently shown to be present in vivo (24) . This cytokine can also be retrogradely transported to the sensory neurons of the DRG, suggesting a role for CDF/LIF as a target-derived neurotrophic molecule for sensory neurons (25) . Further support for this notion is derived from the observations that CDF/LIF rescues motoneurons in culture and in vivo (26, 27) and is expressed in embryonic muscle (19) . On the other hand, we find that during development, expression of CDF/LIF mRNA and its receptor increases from P1 to adulthood in many tissues, indicating a role for the cytokine in normal homeostasis or response to injury in the adult (15) . The fact that CDF/LIF mRNA is up-regulated in adult peripheral ganglia and sciatic nerve suggests that CDF/LIF induction is a general phenomenon in response to injury of the peripheral nervous system. Moreover, CDF/LIF mRNA is expressed in the adult brain at higher levels than in the neonate (19) , suggesting that it might be involved in maintenance of the response to injury in the central nervous system as well. In response to intraperitoneal injection of kainic acid, the CDF/LIF mRNA increases in several brain regions (28) . In addition, after cortical brain lesions, CDF/LIF mRNA reaches a peak of expression at 48 hr and returns to baseline values by 7 days after the lesion (N. Moayeri, L.R.B. and P.H.P., unpublished data).
The increase of CDF/LIF observed in vitro with sciatic nerve explants was verified with in vivo nerve transections. An increase of CDF/LIF mRNA occurs in the regions immediately adjacent to the cut site, both proximal and distal. This increase is rapid, occurring within 24 hr after injury, and is maintained for at least 2 weeks. CDF/LIF mRNA levels in the proximal-2 region do not change relative to control values at any of the times examined, demonstrating that this aspect of the injury response is highly localized. The initial rapid increase in CDF/LIF mRNA expression is somewhat similar to the induction of NGF after sciatic nerve transection. NGF mRNA levels increase dramatically within 6 hr in the regions immediately proximal and distal to the lesion site. This initial increase is followed, however, by a transient decrease between 12 and 24 hr and then by another increase in expression that peaks at 3 days (29). Although we did not examine the response of CDF/LIF 6 hr after transection, we observe a dramatic increase in mRNA expression within 24 hr. The fact that both CDF/LIF and NGF increase rapidly could be related to the observation that both cytokines are inducible by IL-1. The increase in NGF mRNA after sciatic nerve transection is due to the expression of IL-1 by macrophages that invade the lesion site (30) . IL-1 also induces the expression of CDF/LIF in cultured ganglia (12 (32) , but the lack of a signal sequence appears to prevent CNTF from being secreted. After nerve transection, CNTF mRNA levels decrease slightly at 1 day and drastically by 4 days in the regions immediately surrounding the lesion site (33, 34) . CNTF protein levels only decrease slightly, however, and the protein is thought to be present in significant quantities in the extracellular space (34) . The strong early induction in CDF/ LIF mRNA suggests that this factor may be available very soon after damage, and this cytokine is known to be secreted (11, 12 (1994) LIF mRNA in cultured ganglia and nerve gave us the opportunity to define the cell type that expresses the cytokine. As was suggested (11), expression is prominent in nonneuronal cells. The morphology of the digoxigeninlabeled cells in the nerve resemble that of Schwann cells. Although we cannot rule out the possibility that another cell type, such as fibroblasts or macrophages, accounts for some of the staining, two CDF/LIF has been shown to be involved in the response to trauma and infection. This cytokine causes the induction of acute-phase proteins in liver cells (37) . It is rapidly induced in bronchoalveolar fluid in response to lipopolysaccharide injection (T. R. Ulich, M.-J. Fann, P.H.P., J. Williams, B. Samal, J. delCastillo, S. Yin, K. Guo, and D. G. Remick, unpublished data), and it is present at elevated levels in synovial fluids in patients with arthritis (38) . The demonstration of the dramatic induction of CDF/LIF in response to nervous system trauma provides further evidence for the role of this protein in the response to tissue damage.
